eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
 
5/2004
vol. 3
 
Share:
Share:
more
 
 
abstract:

The evaluation of clinical eficacy of 17β-estradiol vaginal tablets in the atropic vaginitis therapy

Edyta Wlaźlak
,
Grzegorz Surkont
,
Jacek Suzin

Prz Menopauz 2004; 5: 24-31
Online publish date: 2004/10/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
In the study 245 women with urogynecologic complaints and estrogen deficiency took part. There was evaluated the eficiency and tolerance of therapy. Conclusions. 1. Vaginal therapy with 25 µg 17β-estradiol tablets is efficient in treatment of atrophic vaginitis and dyspareunia in postmenopausal women. 2. Vaginal therapy with 25 µg 17β-estradiol tablets gives improvement in urinary incontinence complaints in women with estrogen deficiency. 3. Therapy is well tolerated by patients. 4. Vaginal therapy with estradiol tablets in aplicator is noticed by most of the patients as more comfortable than other ways of aplications.
keywords:

vaginal estrogen therapy, atrophic vaginitis, dyspareunia, urinary incontinence, menopause

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe